UK Cancer Detection Firm CanSense Raises £1.5M for Development of Colorectal Cancer Test (360Dx) 0 By Praveen Suthrum on March 13, 2023 Exponential Tech Share Facebook Twitter LinkedIn Pinterest Email CanSense’s test is a blood-based assay that uses laser spectroscopy and artificial intelligence to identify early-stage colorectal cancer and precancerous polyps. Read More Artificial Intelligence Colorectal Cancer
‘A Simple Idea That Could Make a Substantial Impact’: Can a String Replace Endoscopies for Esophageal Cancer, Other Disorders? (University of Colorado)